Saturday, Jan 28th
Last update:07:03:22 AM GMT
Ninety per cent of healthy volunteers given the MVA-B vaccine developed an immune response to HIV in phase I clinical trials.
"MVA-B vaccine has proven to be as powerful as any other vaccine currently being studied, or even more," said Professor Mariano Esteban, at the National Biotech Centre in Madrid, where the vaccine was developed.
MANDERA, 29 September 2011 (IRIN) - An outbreak of dengue fever in Mandera, northeastern Kenya, is s...
Lahore - Already cursed by floods and suicide bombings, Pakistan now faces a new menace from an unpr...
The General Medical Council says some overseas doctors come to the NHS with "little or no preparatio...
But a new study s...
FOREIGN doctors and nurses desperate to practise their skills in South Africa are forced to wait up to six years to be registered by the Health Department.
Health professionals from countries including...
Read more...
Ninety per cent of healthy volunteers given the MVA-B vaccine d...
Read more...
HA NOI — Viet Nam's second successful adult liver transplant was performed at Viet Duc Hospital on Wednesday.
The patient is currently recovering from the 13-hour procedure conducted by the hospital's ...
Read more...
MANDERA, 29 September 2011 (IRIN) - An outbreak of dengue fever in Mandera, northeastern Kenya, is spreading fast, with at least 5,000 people infected within weeks, due to limited health facilities, a...
Read more...